Obesity drug beats others in phase II trial: lowest dose of tesofensine produced weight loss similar to that of sibutramine and rimonabant.(ACROSS ... An article from: Clinical Psychiatry News

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on July 1, 2009. The length of the article is 874 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Obesity drug beats others in phase II trial: lowest dose of tesofensine produced weight loss similar to that of sibutramine and rimonabant.(ACROSS SPECIALTIES)
Author: Miriam E. Tucker
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: July 1, 2009
Publisher: International Medical News Group
Volume: 37 Issue: 7 Page: 27(1)

Distributed by Gale, a part of Cengage Learning